Sogroya® (Somapacitan): The First Once-Weekly Long-Acting Growth Hormone Therapy
Novo Nordisk announced that its innovative growth hormone analogue Sogroya® (somapacitan) has been approved by…
News
Could You Have COPD Without Knowing It?
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions worldwide, causing…
Impavido: A Lifesaving Drug In The Fight Against Leishmaniasis Faces Global Access Challenges
In a world still grappling with neglected tropical diseases, Impavido (generic name: miltefosine) remains one…
Imdelltra (Tarlatamab-Dlle): A Breakthrough In Treating Extensive-Stage Small Cell Lung Cancer
Imdelltra™ (tarlatamab-dlle) represents a significant advancement in the treatment of extensive-stage small cell lung cancer…
Comments Off On Pfizer’s Hympavzi Approved By FDA For Use In Treating Hemophilia Symptoms
HYMPAVZI is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S.…
Fampyra (Fampridine): Enhancing Mobility In Multiple Sclerosis Patients
Fampyra, known generically as fampridine or 4-aminopyridine, is an oral medication approved to improve walking…
Is Hepatitis C Curable? Breaking Down the Myths
Hepatitis C (HCV) is a viral infection that primarily affects the liver, leading to inflammation…
Fetroja (Cefiderocol): A Breakthrough In Combating Multidrug-Resistant Gram-Negative Infections
In the ongoing battle against antimicrobial resistance, Fetroja (cefiderocol) has emerged as a promising solution…
Antizol (Fomepizole): A Critical Antidote In Toxicology
Antizol, the brand name for fomepizole, is an essential antidote used in the treatment of…
Elrexfio A New Hope For Relapsed Or Refractory Multiple Myeloma Patients
In a significant advancement for multiple myeloma treatment, the U.S. Food and Drug Administration (FDA)…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights